MedTrace Logo

Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position

NCT04661124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2025-09-15

No results posted yet for this study

Summary

This is a prospective clinical study conducted at one clinical site in the United States.

Conditions

  • Retinal Disease
  • Healthy Eyes

Interventions

DEVICE

SPECTRALIS

ophthalmic imaging device with head and chinrest

DEVICE

SPECTRALIS with Flex Module

ophthalmic imaging device on mobile instrumentation stand

Sponsors & Collaborators

  • Duke University

    collaborator OTHER

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • Lejla Vajzovic, MD · Duke University

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-10
Primary Completion
2021-09-17
Completion
2024-04-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04661124 on ClinicalTrials.gov